Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships.
Which treatment is best for me? This question is at the centre of the clinical consultation. And yet, too often, the question is not answerable with available evidence on drugs and devices. The two Lancet Series papers on comparative effectiveness 1 , 2 document the shortcomings of the process for...
Main Authors: | Singh, I, Naci, H, Miller, J, Caplan, A, Cipriani, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
The ethical obligations of the mathematics teacher
by: Paul Ernest
Published: (2019-04-01) -
Fear of dementia and the obligation to provide aggregate research results to study participants
by: Graham, M, et al.
Published: (2022) -
Broad medical uncertainty and the ethical obligation for openness
by: Brown, RCH, et al.
Published: (2022) -
Mandatory reporting obligations within the context of health research: Grappling with some of the ethical-legal complexities
by: A Strode, et al.
Published: (2023-05-01) -
Right to health and social justice in Bangladesh: ethical dilemmas and obligations of state and non-state actors to ensure health for urban poor
by: Sohana Shafique, et al.
Published: (2018-06-01)